Leila Alland
Director/Board Member at ABEONA THERAPEUTICS INC.
Net worth: 570 545 $ as of 2024-03-30
Profile
Leila Alland is an Independent Director at Abeona Therapeutics, Inc., a Director at Jubilant Therapeutics, Inc., and a Non-Executive Director at Radiopharm Theranostics Ltd.
She previously worked as a Director at Cytovia Therapeutics, Inc., Chief Medical Officer at Affimed NV, Vice President & Head-Oncology at AstraZeneca LP, and Chief Medical Officer at Tarveda Therapeutics, Inc. She also held the position of Assistant Professor-Pediatrics at Albert Einstein College of Medicine, Inc. and Chief Medical Officer at PMV Pharmaceuticals, Inc. Alland received her undergraduate degree from the University of Pennsylvania and her doctorate from New York University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 67,931 ( 0.25% ) | 492 500 $ | 2024-03-30 | |
| 2023-09-14 | 45,909 ( 0.09% ) | 78 045 $ | 2024-03-30 |
Leila Alland active positions
| Companies | Position | Start |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2021-04-18 |
| RADIOPHARM THERANOSTICS LIMITED | Director/Board Member | 2022-06-05 |
Jubilant Therapeutics, Inc.
 Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Director/Board Member | 2021-08-15 |
Former positions of Leila Alland
| Companies | Position | End |
|---|---|---|
| AFFIMED N.V. | Chief Tech/Sci/R&D Officer | 2019-11-29 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Chief Tech/Sci/R&D Officer | 2018-02-28 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Corporate Officer/Principal | 2015-11-30 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 2000-05-31 |
| PMV PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Leila Alland
| University of Pennsylvania | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| AFFIMED N.V. | Health Technology |
| PMV PHARMACEUTICALS, INC. | Commercial Services |
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Private companies | 4 |
|---|---|
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA. | Health Technology |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
Jubilant Therapeutics, Inc.
Jubilant Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Therapeutics, Inc. operates as a patient-centric biopharmaceutical company. The firm uses advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. The company is headquartered in Bedminster, NJ. | Health Technology |
- Stock Market
- Insiders
- Leila Alland
